CWA Asset Management Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$266K Sell
6,235
-2,770
-31% -$150K 0.01% 617
2026
Q1
$565K Sell
9,005
-1,377
-13% -$110K 0.02% 466
2025
Q4
$990K Sell
10,382
-1,176
-10% -$115K 0.04% 358
2025
Q3
$1.13M Buy
11,558
+349
+3% +$36.1K 0.04% 334
2025
Q2
$1.2M Sell
11,209
-635
-5% -$64.3K 0.05% 297
2025
Q1
$1.19M Buy
11,844
+3,563
+43% +$359K 0.06% 261
2024
Q4
$740K Buy
8,281
+336
+4% +$29.6K 0.04% 316
2024
Q3
$666K Buy
+7,945
New +$626K 0.04% 316
2024
Q1
$219K Sell
3,194
-2,731
-46% -$176K 0.01% 492
2023
Q4
$343K Buy
+5,925
New +$316K 0.02% 306

Other funds holding BSX

CWA Asset Management Group's BSX Position: Q2 2026 in Review

CWA Asset Management Group reduced its Boston Scientific (BSX) stake by 31% in Q2 2026, selling an estimated $150K and leaving 6,235 shares worth $266K. The position accounts for 0.01% of the portfolio, ranked #617.

CWA Asset Management Group first reported a position in BSX in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.2M in Q2 2025. 338 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • CWA Asset Management Group held 6,235 shares of Boston Scientific worth $266K as of Q2 2026.
  • CWA Asset Management Group sold 2,770 Boston Scientific shares in Q2 2026, an estimated $150K.
  • Boston Scientific made up 0.01% of CWA Asset Management Group's portfolio in Q2 2026, its #617 holding.
  • CWA Asset Management Group first reported a position in Boston Scientific in Q4 2023 and has held it in 10 quarters since.
  • CWA Asset Management Group's Boston Scientific position peaked at $1.2M in Q2 2025.
  • 338 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.